About 1,710 results
Open links in new tab
  1. Leading Life Science Research & Clinical Diagnostics | Bio-Rad

    This webinar for educators introduces core concepts and lab techniques used in modern agricultural biotechnology. Participants explore crop improvement, gene insertion into plasmids, GMOs, and …

  2. Bio-Rad Laboratories - Wikipedia

    Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.

  3. Bio-Rad Laboratories - LinkedIn

    Bio-Rad provides the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster,...

  4. Bio-Rad Laboratories, Inc. (BIO) - Yahoo Finance

    Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and...

  5. Bio-Rad - SelectScience

    Bio-Rad Laboratories, Inc. is a multinational manufacturer and distributor of life science research products, clinical diagnostics, and analytical instrumentation, based in Hercules, California.

  6. Bio-Rad Laboratories's All | Lab Manager

    Bio-Rad Laboratories leads in life science research and diagnostics, providing innovative solutions that enable scientists to make impactful discoveries and advancements. With a focus on quality and …

  7. Products — Bio-Rad

    Clinical diagnostics rely on accurate, consistent, and quick sample analysis. With Bio-Rad’s range of systems and products spanning from infectious diseases and bacteriology to molecular diagnostics …

  8. Bio-Rad Laboratories (NYSE:BIO) Shares Gap Down After

    4 days ago · Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) gapped down before the market opened on Friday after the company announced weaker than expected quarterly earnings. The stock …

  9. Bio-Rad Laboratories Q4 Earnings Call Highlights

    4 days ago · Bio-Rad Laboratories (NYSE:BIO) executives said the company finished 2025 within revised guidance for revenue and operating margin, but acknowledged that gross margin …

  10. Bio Rad Laboratories Q3 Loss Of US$12.70 EPS Tests Recovery …

    5 days ago · Bio-Rad Laboratories (BIO) has put up a mixed set of numbers for Q3 FY 2025, with revenue of US$653 million and a basic EPS loss of US$12.70, against a backdrop of prior quarters …